| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.9M | — | -6.7% |
| Cost of Revenue | $16.1M | — | -8.6% |
| Gross Profit | $11.8M | — | -4.0% |
| R&D Expense | $13.7M | — | +42.2% |
| SG&A Expense | $14.6M | — | +3.2% |
| Operating Income | -$23.3M | — | -31.1% |
| Pre-tax Income | -$21.7M | — | -36.0% |
| Income Tax | -$432K | — | +5.3% |
| Net Income | -$22.4M | — | -39.5% |
| EPS (Basic) | -$0.32 | — | -52.4% |
| EPS (Diluted) | -$0.32 | — | -52.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $177.0M | -11.2% | -28.5% |
| Accounts Receivable | $24.8M | +11.7% | +15.3% |
| Inventory | $30.3M | -2.4% | -15.1% |
| Current Assets | $240.8M | -8.1% | -23.3% |
| Total Assets | $379.2M | -6.0% | -17.1% |
| Current Liabilities | $44.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.9M | — | +29.6% |
| Capital Expenditures | $913K | — | +117.4% |
| Investing Cash Flow | -$913K | — | -346.8% |
| Financing Cash Flow | -$6.3M | — | -559.2% |
| Free Cash Flow | -$14.8M | — | +26.5% |
| +73.4% |
| Total Liabilities | $65.8M | +5.6% | +7.4% |
| Stockholders' Equity | $313.3M | -8.1% | -20.9% |